COEXPRESSION OF WILD-TYPE AND VARIANT ESTROGEN-RECEPTOR MESSENGER-RNAS IN A PANEL OF HUMAN BREAST-CANCER CELL-LINES

被引:25
作者
CASTLES, CG
KLOTZ, DM
FUQUA, SAW
HILL, SM
机构
[1] TULANE UNIV,SCH MED,MOLEC & CELLULAR BIOL GRAD PROGRAM,NEW ORLEANS,LA 70112
[2] TULANE UNIV,SCH MED,TULANE CANC CTR,NEW ORLEANS,LA 70112
[3] TULANE UNIV,SCH MED,DEPT ANAT,NEW ORLEANS,LA 70112
[4] UNIV TEXAS,HLTH SCI CTR,DEPT MED ONCOL,SAN ANTONIO,TX 78284
关键词
ESTROGEN RECEPTORS; VARIANTS; BREAST CANCER CELL LINES;
D O I
10.1038/bjc.1995.188
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Wild-type as well as variant oestrogen receptor (ER) mRNAs with exon 5 and 7 deleted were identified in a panel of human breast tumour cell lines by reverse transcriptase-polymerase chain reaction followed by dideoxynucleotide sequence analysis, and then quantitated by ribonuclease protection analysis. All cell lines categorised as ER(+) by ligand-binding analysis expressed both wild-type and variant ER transcripts. Most cell lines classified as ER(-) did not express any ER transcript. However, three ER cell lines (BT-20, MDA-MB-330 and T47D(co)) expressed both wild-type and variant transcripts. A differential pattern of expression of wild type to variant was seen in both ER(+) and ER(-) cell lines, however this pattern was not paralleled by differences in ligand-binding activity. Breast tumour cell lines previously classified as ER(-) expressed significantly lower levels of ER transcripts than did their ER(+) counterparts. In view of these findings, as well as earlier reports that the exon 5 deletion ER variant encodes a dominant-positive receptor, it seems clear that some cell lines are misclassified as ER(-), and express both wild-type and variant ER mRNAs, and that the overexpression of this variant may account, in part, for their oestrogen-independent phenotype.
引用
收藏
页码:974 / 980
页数:7
相关论文
共 29 条
[1]   STEROID-RECEPTORS, CELLULAR KINETICS, AND LYMPH-NODE STATUS AS PROGNOSTIC FACTORS IN BREAST-CANCER [J].
BENNER, SE ;
CLARK, GM ;
MCGUIRE, WL .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1988, 296 (01) :59-66
[2]  
CASTLES CG, 1993, CANCER RES, V53, P5934
[3]   SUPERCOIL SEQUENCING - A FAST AND SIMPLE METHOD FOR SEQUENCING PLASMID DNA [J].
CHEN, EY ;
SEEBURG, PH .
DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1985, 4 (02) :165-170
[4]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[5]   ESTROGEN AND PROGESTERONE-RECEPTOR PROTEINS IN BREAST-CANCER [J].
EDWARDS, DP ;
CHAMNESS, GC ;
MCGUIRE, WL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1979, 560 (04) :457-486
[6]   THE STEROID AND THYROID-HORMONE RECEPTOR SUPERFAMILY [J].
EVANS, RM .
SCIENCE, 1988, 240 (4854) :889-895
[7]   CHARACTERIZATION AND COLOCALIZATION OF STEROID BINDING AND DIMERIZATION ACTIVITIES IN THE MOUSE ESTROGEN-RECEPTOR [J].
FAWELL, SE ;
LEES, JA ;
WHITE, R ;
PARKER, MG .
CELL, 1990, 60 (06) :953-962
[8]   THE ER-POSITIVE PGR-NEGATIVE BREAST-CANCER PHENOTYPE IS NOT ASSOCIATED WITH MUTATIONS WITHIN THE DNA-BINDING DOMAIN [J].
FUQUA, SAW ;
ALLRED, DC ;
ELLEDGE, RM ;
KRIEG, SL ;
BENEDIX, MG ;
NAWAZ, Z ;
OMALLEY, BW ;
GREENE, GL ;
MCGUIRE, WL .
BREAST CANCER RESEARCH AND TREATMENT, 1993, 26 (02) :191-202
[9]  
FUQUA SAW, 1991, CANCER RES, V51, P105
[10]  
FUQUA SAW, 1992, CANCER RES, V52, P483